| Development and validation of a highly sensitive LC‐MS/MS method for simultaneous quantitation of acetyl‐CoA and malonyl‐CoA in animal tissues RR Gilibili, M Kandaswamy, K Sharma, S Giri, S Rajagopal, R Mullangi Biomedical Chromatography 25 (12), 1352-1359, 2011 | 27 | 2011 |
| LC‐MS/MS‐ESI method for simultaneous quantitation of metformin and repaglinidie in rat plasma and its application to pharmacokinetic study in rats K Sharma, G Pawar, S Yadam, S Giri, S Rajagopal, R Mullangi Biomedical Chromatography 27 (3), 356-364, 2013 | 26 | 2013 |
| Highly sensitive method for the determination of adenosine by LC‐MS/MS‐ESI: method validation and scope of application to a pharmacokinetic/pharmacodynamic study K Sharma, R Singh, S Giri, S Rajagopal, R Mullangi Biomedical Chromatography 26 (1), 81-88, 2012 | 18 | 2012 |
| A validated LC–MS/MS method for the estimation of glimepiride and pitavastatin in rat plasma: Application to drug interaction studies S Surendran, D Paul, R Sushmita, L Krishna, NK Tiwari, S Giri, ... Journal of Chromatography B 1046, 218-225, 2017 | 17 | 2017 |
| Novel Bruton tyrosine kinase inhibitor acalabrutinib quantification by validated LC-MS/MS method: An application to pharmacokinetic study in Sprague Dawley rats S Surendran, D Paul, S Pokharkar, S Choulwar, A Deshpande, S Giri, ... Journal of pharmaceutical and biomedical analysis 164, 509-513, 2019 | 14 | 2019 |
| A highly sensitive LC‐MS/MS method for the determination of S‐citalopram in rat plasma: application to a pharmacokinetic study in rats PS Suresh, S Giri, R Husain, R Mullangi Biomedical Chromatography 24 (10), 1052-1058, 2010 | 14 | 2010 |
| LC–MS/MS-ESI method for simultaneous quantitation of three endocannabinoids and its application to rat pharmacokinetic studies K Sharma, RR Singh, M Kandaswamy, C Mithra, S Giri, S Rajagopal, ... Bioanalysis 3 (2), 181-196, 2011 | 11 | 2011 |
| Highly sensitive LC‐MS/MS‐ESI method for simultaneous quantitation of albendazole and ricobendazole in rat plasma and its application to a rat pharmacokinetic study K Sharma, M Kandaswamy, C Mithra, AK Meena, S Giri, S Rajagopal, ... Biomedical Chromatography 26 (2), 247-255, 2012 | 10 | 2012 |
| A LC-MS/MS method for simultaneous estimation of a novel anti-diabetic combination of saxagliptin and dapagliflozin using a polarity switch approach: application to in vivo rat … S Surendran, D Paul, S Pokharkar, A Deshpande, S Giri, ... Analytical methods 11 (2), 219-226, 2019 | 9 | 2019 |
| Evaluation of herb-drug interaction of Synacinn™ and individual biomarker through cytochrome 450 inhibition assay NS Ab Rahman, FA Abd Majid, ME Abd Wahid, AN Zainudin, SN Zainol, ... Drug metabolism letters 12 (1), 62-67, 2018 | 9 | 2018 |
| A highly sensitive LC‐MS/MS method for the determination of S‐raclopride in rat plasma: application to a pharmacokinetic study in rats SPSRR Punde, M Gupta, A Dixit, S Giri, S Rajagopal, R Mullangi Biomedical Chromatography 25 (8), 930-937, 2011 | 7 | 2011 |
| Pharmacokinetics, tissue distribution and identification of putative metabolites of JI-101–a novel triple kinase inhibitor in rats SD Gurav, RR Gilibili, S Jeniffer, Z Mohd, S Giri, R Govindarajan, ... Arzneimittelforschung 62 (01), 27-34, 2012 | 6 | 2012 |
| In vitro evaluation of reactive nature of E-and Z-guggulsterones and their metabolites in human liver microsomes using UHPLC-Orbitrap mass spectrometer A Balhara, M Ladumor, DK Singh, P Praneetha, J Preethi, S Pokharkar, ... Journal of Pharmaceutical and Biomedical Analysis 186, 113275, 2020 | 5 | 2020 |
| Development and validation of a liquid chromatography-tandem mass spectrometry method for quantitation of indomethacin in rat plasma and its application to a pharmacokinetic … PS Suresh, A Dixit, S Giri, S Rajagopal, R Mullangi Biomedical Chromatography: BMC 27 (4), 496-501, 2012 | 5 | 2012 |
| Efficacy and safety of highly selective novel IRAK4 inhibitors for treatment of ABC-DLBCL WR Balasubramanian, VR Gummadi, K Nellore, S Mukherjee, ... Cancer Res 76 (14_Supplement), 2016 | 4 | 2016 |
| Highly sensitive method for the determination of a novel triple kinase inhibitor with anti‐cancer activity, JI‐101, in rat plasma by liquid chromatography–electrospray … SD Gurav, RR Gilibili, S Jeniffer, S Giri, NR Srinivas, R Mullangi Biomedical Chromatography 25 (7), 794-800, 2011 | 3 | 2011 |
| Oral bioavailability, permeability, CYP profiling, identification of major metabolites, tissue distribution and excretion profile of a novel triple kinase inhibitor, JI-101 in rats SD Gurav, RR Gilibili, S Jeniffer, M Zainuddin, S Giri, R Govindrajan, ... Cancer Research 71 (8_Supplement), 3286-3286, 2011 | 3 | 2011 |
| Targeting cancer with selective cbp/p300 bromodomain inhibitors M Jaleel, RS Senaiar, C Abbineni, GA Renukappa, S Mukherjee, ... Cancer Research 80 (16_Supplement), 1753-1753, 2020 | 1 | 2020 |
| Safety, tolerability, pharmacokinetics and pharmacodynamics of AUR101, An ROR gamma t inhibitor, in normal healthy volunteers D Mandavia, N Farinola, M Ramachandra, K Nellore, S Giri, K Narayanan, ... ALLERGY 74, 569-570, 2019 | 1 | 2019 |
| Discovery and preclinical evaluation of a novel covalent inhibitor of FABP5 for cancer therapy D Chikkanna, LK Satyam, SK Pnaigrahi, V Khairnar, M Pothuganti, ... Cancer Research 81 (13_Supplement), 1266-1266, 2021 | | 2021 |
